RxDoctor Payments Data

Derrick Henry, MD

Foot and Ankle Surgery · Little Rock, ARNPI 1417453234

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (55.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Arthrex at 55.2% of the total. Reporting peaked in 2023 at $10,767 and has fallen 53.1% since, to $5,045 in 2025.

$18,120in general payments, 2019–2025

Across 35 payments — averaging $517.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$10K
  • Vilex LLC$5K
  • Exactech, Inc.$2K
  • Stryker$960
  • Medshape, Inc.$303
  • Trilliant Surgical LLC.$276
  • plus $112 from 1 others

What the payments were for

  • Consulting fees$2,50014%
  • Grants$10,00055%
  • Travel & lodging$3,08817%
  • Food & beverage$2,53214%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex1$10,000
Vilex LLC8$4,780
Exactech, Inc.7$1,690
Stryker11$960
Medshape, Inc.4$303
Trilliant Surgical LLC.3$276
Johnson & Johnson1$112

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,120 in reported general payments places this provider in the 85th percentile of 35 foot and ankle surgery providers in Arkansas.

See all foot and ankle surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$60,142
Medicare patients
189
Services billed
686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl36$191
Ondansetron OdtOndansetron28$182
Meloxicam48$168
Methylprednisolone21$143
Cyclobenzaprine Hcl14$47

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →